Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Glioblastoma (GBM) is a cancer type with high thrombogenic potential and GBM patients are therefore at a particularly high risk for thrombotic events. To date, only limited data on anticoagulation management after pulmonary embolism (PE) in GBM is available and the sporadic use of DOACs remains off-...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinski, Daniel, Won, Sae-Yeon, Voss, Martin, Keil, Fee, Miesbach, Wolfgang, Behmanesh, Bedjan, Dosch, Max, Baumgarten, Peter, Bernstock, Joshua D., Seifert, Volker, Freiman, Thomas M., Gessler, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827361/
https://www.ncbi.nlm.nih.gov/pubmed/33900495
http://dx.doi.org/10.1007/s10143-021-01539-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827361/
https://www.ncbi.nlm.nih.gov/pubmed/33900495
http://dx.doi.org/10.1007/s10143-021-01539-9

Ejemplares similares